On 2 June, the Prevention of Dementia using Mobile phone Applications (PRODEMOS) project held its final General Assembly meeting in Amsterdam. Since January 2017, partners of this EU-H2020 project have been working together to make an evidence-based dementia prevention strategy using mobile Health (mHealth), accessible to those at increased risk of dementia. PRODEMOS builds on an existing eHealth intervention that is adapted to an mHealth platform for dementia prevention, specifically tailored to vulnerable populations in High Income Countries (HIC) and in Low and Middle Income Countries (LMIC), and has been implemented in multiple settings in the UK and China to pave the way towards a scalable, global strategy for dementia risk reduction. Chaired by Edo Richard and Eric Moll Van Charante from the Academic Medical Centre Amsterdam (AMC), the meeting was attended by representatives from the institutions and organisations that make up the project’s consortium, including Alzheimer Europe.
Executive Director Jean Georges and Project Officer Cindy Birck attended the meeting on behalf of Alzheimer Europe. During the meeting, partners highlighted key project developments and achievements. Trial results were presented including its efficacy, implementation and the cost-effectiveness analysis. In addition, Chinese partners presented an overview on additional measurements and shared some experiences from the trial such as challenges and opportunities. Finally, partners looked back at accomplishments and setbacks before to officially drew the meeting to a close. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779238 and the National Key R&D Programme of China (2017YFE0118800). Further information on the PRODEMOS project can be found here:
